Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Strains-Distribution of the Essential Enzymatic Virulence Factors Genes

<i>Pseudomonas aeruginosa</i> is one of the most commonly isolated bacteria from clinical specimens, with increasing isolation frequency in nosocomial infections. Herein, we investigated whether antimicrobial-resistant <i>P. aeruginosa</i> strains, e.g., metallo-beta-lactamas...

Full description

Bibliographic Details
Published in:	Antibiotics
Main Authors:	Tomasz Bogiel, Małgorzata Prażyńska, Joanna Kwiecińska-Piróg, Agnieszka Mikucka, Eugenia Gospodarek-Komkowska
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Subjects:	carbapenems carbapenem-resistant <i>Pseudomonas aeruginosa</i> <i>Pseudomonas aeruginosa</i> <i>Pseudomonas aeruginosa</i> genotypes <i>Pseudomonas aeruginosa</i> virulence resistance to carbapenems
Online Access:	https://www.mdpi.com/2079-6382/10/1/8

Similar Items

Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum Model
by: Vaughn D. Craddock, et al.
Published: (2023-06-01)

Characterization of Antimicrobial Resistance Mechanisms and Virulence Determinants in Colistin- and Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Ellappan Kalaiarasan, et al.
Published: (2024-09-01)

Prevalence of the Genes Associated with Biofilm and Toxins Synthesis amongst the <i>Pseudomonas aeruginosa</i> Clinical Strains
by: Tomasz Bogiel, et al.
Published: (2021-02-01)

Characterization of <i>bla</i><sub>KPC-2</sub>-Carrying Plasmid pR31-KPC from a <i>Pseudomonas aeruginosa</i> Strain Isolated in China
by: Min Yuan, et al.
Published: (2021-10-01)

It’s Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant <i>Pseudomonas aeruginosa</i>
by: Payam Behzadi, et al.
Published: (2021-01-01)

Characterization, Genomic Analysis and Application of Five Lytic Phages Against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Li-Ping Zhang, et al.
Published: (2025-07-01)

Outbreak of Carbapenem-Resistant High-Risk Clone ST244 of <i>Pseudomonas aeruginosa</i> in Dogs and Cats in Algeria
by: Amina Badis, et al.
Published: (2025-02-01)

Carbapenem-resistant Pseudomonas aeruginosa outbreak in an intensive care unit of a teaching hospital
by: Ana C. Gales, et al.

Multiple Mechanisms Synergistically Induce Pseudomonas Aeruginosa Multiple Drug Resistance
by: Pei Dai, et al.
Published: (2023-05-01)

Sources and Transmission Routes of Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>: Study Design and Methodology of the SAMPAN Study
by: Anneloes van Veen, et al.
Published: (2025-01-01)

Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
by: Márió Gajdács
Published: (2020-04-01)

Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems
by: Chia-Hsin Lee, et al.
Published: (2017-10-01)

Bloodstream Infections Due to Wild-Type <i>Pseudomonas aeruginosa</i>: Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes
by: Carlo Pallotto, et al.
Published: (2024-08-01)

The Effect of Decreased Antipseudomonal Drug Consumption on <i>Pseudomonas aeruginosa</i> Incidence and Antimicrobial Susceptibility Profiles over 9 Years in a Lebanese Tertiary Care Center
by: Rima El-Basst, et al.
Published: (2023-01-01)

Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, <i>Acinetobacter baumannii</i>: A Multicenter Study in China
by: Xuemei Zhen, et al.
Published: (2020-08-01)

Rapid Reversal of Carbapenemase-Producing <i>Pseudomonas aeruginosa</i> Epidemiology from <i>bla</i><sub>VIM</sub>- to <i>bla</i><sub>NDM</sub>-harbouring Isolates in a Greek Tertiary Care Hospital
by: Efthymia Protonotariou, et al.
Published: (2024-08-01)

Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>
by: Anthony Sophonsri, et al.
Published: (2024-05-01)

Molecular insights into the persistence and co-occurrence of two different carbapenem-resistant Pseudomonas aeruginosa lineages within a hospital setting
by: Xinran Li, et al.
Published: (2025-10-01)

In Vitro and Pre-Clinical Evaluation of Locally Isolated Phages, vB_Pae_SMP1 and vB_Pae_SMP5, Formulated as Hydrogels against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Samar S. Mabrouk, et al.
Published: (2022-12-01)

Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Bacteremia, through a Six-Year Infection Control Program in a Hospital
by: Amalia Papanikolopoulou, et al.
Published: (2023-05-01)

National Cohort of Compassionate Use of Meropenem–Vaborbactam: No Benefit over Meropenem for <i>Pseudomonas aeruginosa</i>
by: Aurélien Dinh, et al.
Published: (2024-12-01)

Innovative Antibiotic Therapies for Carbapenem-Resistant Gram-Negative Bacterial Infections: Clinical Efficacy, Safety, and Comparative Studies
by: Majid Eslami, et al.
Published: (2025-01-01)

The Impact of the Virulence of <i>Pseudomonas aeruginosa</i> Isolated from Dogs
by: Telma de Sousa, et al.
Published: (2023-05-01)

Antimicrobial Resistance and Mortality in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Infections in Southern Thailand
by: Parichart Chotimakorn, et al.
Published: (2025-03-01)

Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Addisu D. Teklemariam, et al.
Published: (2023-03-01)

Genetic Diversity, Biofilm Formation, and Antibiotic Resistance of <i>Pseudomonas aeruginosa</i> Isolated from Cow, Camel, and Mare with Clinical Endometritis
by: Samy F. Mahmoud, et al.
Published: (2022-05-01)

Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa
by: Li-Hsin Tsao, et al.
Published: (2018-06-01)

Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China
by: Yiwei Zhu, et al.
Published: (2021-12-01)

Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
by: Li S, et al.
Published: (2018-08-01)

Clinical Significance of Carbapenem-Tolerant <i>Pseudomonas aeruginosa</i> Isolated in the Respiratory Tract
by: Momoyo Azuma, et al.
Published: (2020-09-01)

Molecular study of carbapenem-resistant Pseudomonas aeruginosa causing wound infection in an Egyptian tertiary hospital
by: Nagwan Galal El Menofy, et al.
Published: (2025-07-01)

Effects of synthetic peptide RP557 and its origin, LL-37, on carbapenem-resistant Pseudomonas aeruginosa
by: Yun-Qi Song, et al.
Published: (2023-10-01)

Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
by: Namareq F. Aldardeer, et al.
Published: (2024-12-01)

Survey on Carbapenem-Resistant Bacteria in Pigs at Slaughter and Comparison with Human Clinical Isolates in Italy
by: Silvia Bonardi, et al.
Published: (2022-06-01)

Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases
by: Sisi Zhen, et al.
Published: (2023-06-01)

Specific variants in ftsI reduce carbapenem susceptibility in Pseudomonas aeruginosa
by: Hirokazu Yano, et al.
Published: (2025-08-01)

Insights into the Rising Threat of Carbapenem-Resistant Enterobacterales and <i>Pseudomonas aeruginosa</i> Epidemic Infections in Eastern Europe: A Systematic Literature Review
by: Michal Piotrowski, et al.
Published: (2024-10-01)

First Detection and Molecular Characterization of <i>Pseudomonas aeruginosa bla</i><sub>NDM-1</sub> ST308 in Greece
by: Katerina Tsilipounidaki, et al.
Published: (2023-08-01)

An Assessment Of Cefiderocol's Synergistic Effects With Eravacycline, Colistin, Meropenem, Levofloxacin, Ceftazidime/Avibactam, And Tobramycin Against Carbapenem-Resistant Pseudomonas Aeruginosa
by: Bekir Özer, et al.
Published: (2024-12-01)

Prevalence of carbapenem resistance genes in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii from meat samples
by: Maryam Rezaeian, et al.
Published: (2025-01-01)